SIC researchers have found that Staph aureus on the skin releases toxins that activate both normal and cancerous T cells, leading to destruction of the skin barrier. Treatment with a new drug candidate, endolysins, can remove the bacteria and restore skin barrier function.
sic.ku.dk/news/2026/st...
Researchers from the LEO Foundation Skin Immunology Research Center (SIC) have made new insights into how Staphylococcus aureus augments skin barrier damage in Cutaneous T cell lym...
sic.ku.dk
LEO Foundation Skin Immunology Research Center (SIC)
